Literature DB >> 22726859

Completeness of case ascertainment for surveillance of autism spectrum disorders using the autism developmental disabilities monitoring network methodology.

Joyce S Nicholas1, Laura A Carpenter, Lydia B King, Walter Jenner, Amy Wahlquist, Sarah Logan, Jane M Charles.   

Abstract

BACKGROUND: The Autism and Developmental Disabilities Monitoring Network (ADDM), sponsored by the Centers for Disease Control and Prevention, is the largest-scale project ever undertaken to identify the prevalence of Autism Spectrum Disorders (ASD) in the United States.
OBJECTIVE: The objective of the present study was to examine the accuracy of the ADDM methodology in terms of completeness of case ascertainment; that is, to assess the success of the ADDM Network in identifying and accurately classifying all existing cases of ASD among 8-year-old children in the target study areas.
METHODS: To accomplish this objective, the ADDM methodology was applied to a selected region of South Carolina for 8-year olds in 2000 (birth year 1992) and again seven years later for the same region and birth year.
RESULTS: For this region and birth year, completeness of case ascertainment was high, with prevalence estimates of 7.6 per 1000 at both ages 8- and 15-years. For children common to both surveillance years, concordance in case status was also high (82%).
CONCLUSIONS: Given that prevalence did not change within this region and birth year, continued research is needed to better understand the changes in prevalence estimates being found by the ADDM network across surveillance groups.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22726859      PMCID: PMC4165334          DOI: 10.1016/j.dhjo.2012.03.004

Source DB:  PubMed          Journal:  Disabil Health J        ISSN: 1876-7583            Impact factor:   2.554


  6 in total

1.  Evaluation of a records-review surveillance system used to determine the prevalence of autism spectrum disorders.

Authors:  Rachel Nonkin Avchen; Lisa D Wiggins; Owen Devine; Kim Van Naarden Braun; Catherine Rice; Nancy C Hobson; Diana Schendel; Marshalyn Yeargin-Allsopp
Journal:  J Autism Dev Disord       Date:  2011-02

2.  Changes in autism spectrum disorder prevalence in 4 areas of the United States.

Authors:  Catherine Rice; Joyce Nicholas; Jon Baio; Sydney Pettygrove; Li-Ching Lee; Kim Van Naarden Braun; Nancy Doernberg; Chris Cunniff; Craig Newschaffer; F John Meaney; Jane Charles; Anita Washington; Lydia King; Maria Kolotos; Kristen Mancilla; Cynthia A Mervis; Laura Carpenter; Marshalyn Yeargin-Allsopp
Journal:  Disabil Health J       Date:  2010-01-04       Impact factor: 2.554

3.  Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006.

Authors: 
Journal:  MMWR Surveill Summ       Date:  2009-12-18

4.  A public health collaboration for the surveillance of autism spectrum disorders.

Authors:  Catherine E Rice; Jon Baio; Kim Van Naarden Braun; Nancy Doernberg; F John Meaney; Russell S Kirby
Journal:  Paediatr Perinat Epidemiol       Date:  2007-03       Impact factor: 3.980

5.  Evaluation of a methodology for a collaborative multiple source surveillance network for autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2002.

Authors:  Kim Van Naarden Braun; Sydney Pettygrove; Julie Daniels; Lisa Miller; Joyce Nicholas; Jon Baio; Laura Schieve; Russell S Kirby; Anita Washington; Sally Brocksen; Hossein Rahbar; Catherine Rice
Journal:  MMWR Surveill Summ       Date:  2007-02-09

6.  Prevalence of autism spectrum disorders--autism and developmental disabilities monitoring network, six sites, United States, 2000.

Authors: 
Journal:  MMWR Surveill Summ       Date:  2007-02-09
  6 in total
  5 in total

1.  Variation in socio-economic burden for caring of children with autism spectrum disorder in Oman: caregiver perspectives.

Authors:  Yahya M Al-Farsi; Mostafa I Waly; Marwan M Al-Sharbati; Mohamed Al-Shafaee; Omar Al-Farsi; Samiya Al-Fahdi; Allal Ouhtit; Maha Al-Khaduri; Samir Al-Adawi
Journal:  J Autism Dev Disord       Date:  2013-05

2.  Rates and predictors of adherence to psychotropic medications in children with autism spectrum disorders.

Authors:  Sarah L Logan; Laura Carpenter; R Scott Leslie; Kelly S Hunt; Elizabeth Garrett-Mayer; Jane Charles; Joyce S Nicholas
Journal:  J Autism Dev Disord       Date:  2014-11

3.  High prescription drug use and associated costs among Medicaid-eligible children with autism spectrum disorders identified by a population-based surveillance network.

Authors:  Sarah L Logan; Joyce S Nicholas; Laura A Carpenter; Lydia B King; Elizabeth Garrett-Mayer; Jane M Charles
Journal:  Ann Epidemiol       Date:  2012-01       Impact factor: 3.797

4.  Defining in Detail and Evaluating Reliability of DSM-5 Criteria for Autism Spectrum Disorder (ASD) Among Children.

Authors:  C E Rice; L A Carpenter; M J Morrier; C Lord; M DiRienzo; A Boan; C Skowyra; A Fusco; J Baio; A Esler; W Zahorodny; N Hobson; A Mars; A Thurm; S Bishop; L D Wiggins
Journal:  J Autism Dev Disord       Date:  2022-01-04

5.  Aberrant Behaviors and Co-occurring Conditions as Predictors of Psychotropic Polypharmacy among Children with Autism Spectrum Disorders.

Authors:  Sarah L Logan; Laura Carpenter; R Scott Leslie; Elizabeth Garrett-Mayer; Kelly J Hunt; Jane Charles; Joyce S Nicholas
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-04-28       Impact factor: 2.576

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.